Mycoplasma genitalium in the US (MyGeniUS): Surveillance Data From Sexual Health Clinics in 4 US Regions
LE Manhart, G Leipertz, OO Soge… - Clinical Infectious …, 2023 - academic.oup.com
Background Mycoplasma genitalium (MG) is on the CDC Watch List of Antimicrobial
Resistance Threats, yet there is no systematic surveillance to monitor change. Methods We …
Resistance Threats, yet there is no systematic surveillance to monitor change. Methods We …
Mycoplasma genitalium in the US (mygenius): surveillance data from sexual health clinics in 4 US regions.
LE Manhart, G Leipertz, OO Soge, SJ Jordan, C McNeil… - 2023 - cabidigitallibrary.org
Background: Mycoplasma genitalium (MG) is on the CDC Watch List of Antimicrobial
Resistance Threats, yet there is no systematic surveillance to monitor change. Methods: We …
Resistance Threats, yet there is no systematic surveillance to monitor change. Methods: We …
Mycoplasma genitalium in the US (MyGeniUS): Surveillance Data From Sexual Health Clinics in 4 US Regions
LE Manhart, G Leipertz, OO Soge… - Clinical Infectious …, 2023 - academic.oup.com
Background Mycoplasma genitalium (MG) is on the CDC Watch List of Antimicrobial
Resistance Threats, yet there is no systematic surveillance to monitor change. Methods We …
Resistance Threats, yet there is no systematic surveillance to monitor change. Methods We …
[HTML][HTML] Mycoplasma genitalium in the US (MyGeniUS): Surveillance Data From Sexual Health Clinics in 4 US Regions
LE Manhart, G Leipertz, OO Soge… - … Diseases: An Official …, 2023 - ncbi.nlm.nih.gov
Background Mycoplasma genitalium (MG) is on the CDC Watch List of Antimicrobial
Resistance Threats, yet there is no systematic surveillance to monitor change. Methods We …
Resistance Threats, yet there is no systematic surveillance to monitor change. Methods We …
Mycoplasma genitalium in the US (MyGeniUS): Surveillance Data From Sexual Health Clinics in 4 US Regions
MyGeniUS Study Team - … diseases: an official publication of the …, 2023 - profiles.wustl.edu
BACKGROUND: Mycoplasma genitalium (MG) is on the CDC Watch List of Antimicrobial
Resistance Threats, yet there is no systematic surveillance to monitor change. METHODS …
Resistance Threats, yet there is no systematic surveillance to monitor change. METHODS …
Mycoplasma genitalium in the US (MyGeniUS): Surveillance data from sexual health clinics in 4 US regions
LE Manhart, G Leipertz, OO Soge, SJ Jordan, C McNeil… - 2023 - digitalcommons.wustl.edu
Background. Mycoplasma genitalium (MG) is on the CDC Watch List of Antimicrobial
Resistance Threats, yet there is no systematic surveillance to monitor change. Methods. We …
Resistance Threats, yet there is no systematic surveillance to monitor change. Methods. We …
Mycoplasma genitalium in the US (MyGeniUS): Surveillance Data From Sexual Health Clinics in 4 US Regions
LE Manhart, G Leipertz, OO Soge… - … publication of the …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Mycoplasma genitalium (MG) is on the CDC Watch List of Antimicrobial
Resistance Threats, yet there is no systematic surveillance to monitor change. Methods We …
Resistance Threats, yet there is no systematic surveillance to monitor change. Methods We …
Mycoplasma genitalium in the US (MyGeniUS): Surveillance Data from Sexual Health Clinics in Four US Regions.
LE Manhart, G Leipertz, OO Soge… - … Diseases: an Official …, 2023 - europepmc.org
Background Mycoplasma genitalium (MG) is on the CDC Watch List of Antimicrobial
Resistance Threats yet there is no systematic surveillance to monitor change. Methods We …
Resistance Threats yet there is no systematic surveillance to monitor change. Methods We …
Mycoplasma genitalium in the US (MyGeniUS): Surveillance Data from Sexual Health Clinics in Four US Regions.
LE Manhart, G Leipertz, OO Soge… - … Diseases: an Official …, 2023 - europepmc.org
Background Mycoplasma genitalium (MG) is on the CDC Watch List of Antimicrobial
Resistance Threats yet there is no systematic surveillance to monitor change. Methods We …
Resistance Threats yet there is no systematic surveillance to monitor change. Methods We …